foxo4 dri human trial senolytic

foxo4 dri human trial senolytic Development of a novel by precise disruption of FOXO4-p53 complex The disordered p53 transactivation domain

Name: foxo4 dri human trial senolytic Development of a novel by precise disruption of FOXO4-p53 complex The disordered p53 transactivation domain
Brand: cantondelareina.com.ar
SKU: 5990351230
Price: 27.20 USD
Availability: InStock
Rating: 4.6930000000000005 (10 reviews)

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Averix Labs Buy FOXO4 DRI 10mg Peptide EU Tested Particle Peptides Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry

SKU: 5990351230 · From cantondelareina.com.ar

4.7

USD27.20 USD69.20

Pay in 4 interest-free payments of $6.80 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

It has been determined that a specific aminopeptidase-like enzyme is responsible for its low molecular stability in vitro, with a half-life of barely 15 minutes